David O'Toole serves as the Chief Financial Officer (CFO) at AVITA MEDICAL, INC., a regenerative medicine company focused on developing and commercializing innovative treatments for skin restoration and regeneration. In his role as CFO, O'Toole is responsible for overseeing the financial operations of the company, including financial planning and analysis, accounting, and investor relations. His strategic leadership has been instrumental in guiding AVITA MEDICAL through its growth phases, ensuring the company's financial stability and supporting its mission to bring advanced medical solutions to patients worldwide. Before joining AVITA MEDICAL, O'Toole amassed extensive experience in the financial sector, working with both public and private companies across various industries. He previously held the position of CFO at a leading biotechnology firm, where he played a key role in navigating the company through several successful funding rounds and a significant merger. O'Toole's expertise in financial strategy and corporate development has been crucial in driving the growth and operational efficiency of the organizations he has served. His background also includes significant experience in the healthcare sector, making him a valuable asset to AVITA MEDICAL as it continues to expand its product offerings and market presence. O'Toole holds a Bachelor's degree in Finance from a prestigious university and is a Certified Public Accountant (CPA). His commitment to excellence and deep understanding of financial management have earned him recognition within the industry. At AVITA MEDICAL, he continues to leverage his skills to support the company's goals, working closely with the executive team to advance the development and commercialization of groundbreaking medical technologies. Under his financial stewardship, AVITA MEDICAL is well-positioned to achieve its objectives and make a lasting impact on patient care.